These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

113 related articles for article (PubMed ID: 25789946)

  • 1. No differences of immune activation and microbial translocation among HIV-infected children receiving combined antiretroviral therapy or protease inhibitor monotherapy.
    Falcon-Neyra L; Benmarzouk-Hidalgo OJ; Madrid L; Noguera-Julian A; Fortuny C; Neth O; López-Cortés L
    Medicine (Baltimore); 2015 Mar; 94(11):e521. PubMed ID: 25789946
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Differential effects of viremia and microbial translocation on immune activation in HIV-infected patients throughout ritonavir-boosted darunavir monotherapy.
    BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutiérrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
    Medicine (Baltimore); 2015 May; 94(17):e781. PubMed ID: 25929922
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Correlation between different methods to measure microbial translocation and its association with immune activation in long-term suppressed HIV-1-infected individuals.
    Abad-Fernández M; Vallejo A; Hernández-Novoa B; Díaz L; Gutiérrez C; Madrid N; Muñoz MA; Moreno S
    J Acquir Immune Defic Syndr; 2013 Oct; 64(2):149-53. PubMed ID: 24047967
    [TBL] [Abstract][Full Text] [Related]  

  • 4. HIV-1 p24 and CD4
    Benmarzouk-Hidalgo OJ; Torres-Cornejo A; Gutierrez-Valencia A; Viciana P; López-Cortés LF
    Enferm Infecc Microbiol Clin; 2017 Mar; 35(3):174-178. PubMed ID: 26976380
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased gut microbial translocation in HIV-infected children persists in virologic responders and virologic failures after antiretroviral therapy.
    Pilakka-Kanthikeel S; Huang S; Fenton T; Borkowsky W; Cunningham CK; Pahwa S
    Pediatr Infect Dis J; 2012 Jun; 31(6):583-91. PubMed ID: 22333700
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Long-term Use of Proton Pump Inhibitors Is Associated With Increased Microbial Product Translocation, Innate Immune Activation, and Reduced Immunologic Recovery in Patients With Chronic Human Immunodeficiency Virus-1 Infection.
    Serpa JA; Rueda AM; Somasunderam A; Utay NS; Lewis D; Couturier JP; Breaux KG; Rodriguez-Barradas M
    Clin Infect Dis; 2017 Oct; 65(10):1638-1643. PubMed ID: 29020215
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immune activation throughout a boosted darunavir monotherapy simplification strategy.
    BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutiérrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
    Clin Microbiol Infect; 2014 Dec; 20(12):1297-303. PubMed ID: 24372830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Higher Activation in CD4(+) T Cells But Similar Viral Control Among HIV/Hepatitis C Virus-Coinfected Patients on a Simplification Monotherapy.
    BenMarzouk-Hidalgo OJ; Torres-Cornejo A; Gutierrez-Valencia A; Ruiz-Valderas R; Viciana P; López-Cortés LF
    AIDS Res Hum Retroviruses; 2016 Jan; 32(1):6-11. PubMed ID: 26414169
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Microbial translocation and T cell activation are not associated in chronic HIV-infected children.
    Madrid L; Noguera-Julian A; Falcon-Neyra L; Fortuny C; De Felipe B; Torrebadell M; Sanchez B; Valls A; López-Cortès L; Benmarzouk-Hidalgo OJ; Neth O
    AIDS; 2014 Aug; 28(13):1989-92. PubMed ID: 25259707
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Microbial Translocation and Immune Activation in HIV-1 Infected Pregnant Women.
    Mitchell CD; Dominguez S; Roach M; George V; Rinaldi S; Fischl M; Potter J; Tyson B; Pahwa S
    Curr HIV Res; 2018; 16(3):208-215. PubMed ID: 30062968
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Protease inhibitor resistance in South African children with virologic failure.
    van Zyl GU; van der Merwe L; Claassen M; Cotton MF; Rabie H; Prozesky HW; Preiser W
    Pediatr Infect Dis J; 2009 Dec; 28(12):1125-7. PubMed ID: 19779394
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immune activation is associated with increased gut microbial translocation in treatment-naive, HIV-infected children in a resource-limited setting.
    Pilakka-Kanthikeel S; Kris A; Selvaraj A; Swaminathan S; Pahwa S
    J Acquir Immune Defic Syndr; 2014 May; 66(1):16-24. PubMed ID: 24378729
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effects of Co-Trimoxazole on Microbial Translocation in HIV-1-Infected Patients Initiating Antiretroviral Therapy.
    Vesterbacka J; Barqasho B; Häggblom A; Nowak P
    AIDS Res Hum Retroviruses; 2015 Aug; 31(8):830-6. PubMed ID: 26059763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Protease inhibitor monotherapy is associated with a higher level of monocyte activation, bacterial translocation and inflammation.
    Torres B; Guardo AC; Leal L; Leon A; Lucero C; Alvarez-Martinez MJ; Martinez MJ; Vila J; Martínez-Rebollar M; González-Cordón A; Gatell JM; Plana M; García F
    J Int AIDS Soc; 2014; 17(1):19246. PubMed ID: 25280865
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immune Reconstitution in Severely Immunosuppressed Antiretroviral-Naive HIV-1-Infected Patients Starting Efavirenz, Lopinavir-Ritonavir, or Atazanavir-Ritonavir Plus Tenofovir/Emtricitabine: Final 48-Week Results (The Advanz-3 Trial).
    Miro JM; Manzardo C; Ferrer E; Loncà M; Guardo AC; Podzamczer D; Domingo P; Curran A; Clotet B; Cruceta A; Lozano F; Pérez I; Plana M; Gatell JM;
    J Acquir Immune Defic Syndr; 2015 Jun; 69(2):206-15. PubMed ID: 25831464
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Impact of HIV Infection and Anti-Retroviral Therapy on the Immune Profile of and Microbial Translocation in HIV-Infected Children in Vietnam.
    Bi X; Ishizaki A; Nguyen LV; Matsuda K; Pham HV; Phan CT; Ogata K; Giang TT; Phung TT; Nguyen TT; Tokoro M; Pham AN; Khu DT; Ichimura H
    Int J Mol Sci; 2016 Aug; 17(8):. PubMed ID: 27490536
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malnutrition in HIV-Infected Children Is an Indicator of Severe Disease with an Impaired Response to Antiretroviral Therapy.
    Muenchhoff M; Healy M; Singh R; Roider J; Groll A; Kindra C; Sibaya T; Moonsamy A; McGregor C; Phan MQ; Palma A; Kloverpris H; Leslie A; Bobat R; LaRussa P; Ndung'u T; Goulder P; Sobieszczyk ME; Archary M
    AIDS Res Hum Retroviruses; 2018 Jan; 34(1):46-55. PubMed ID: 28670966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Differential effects of antiretrovirals on microbial translocation and gut microbiota composition of HIV-infected patients.
    Villanueva-Millán MJ; Pérez-Matute P; Recio-Fernández E; Lezana Rosales JM; Oteo JA
    J Int AIDS Soc; 2017 Mar; 20(1):21526. PubMed ID: 28362071
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Simplification to rilpivirine/emtricitabine/tenofovir disoproxil fumarate from ritonavir-boosted protease inhibitor antiretroviral therapy in a randomized trial of HIV-1 RNA-suppressed participants.
    Palella FJ; Fisher M; Tebas P; Gazzard B; Ruane P; Van Lunzen J; Shamblaw D; Flamm J; Ebrahimi R; Porter D; White K; Hindman J; Elbert E; De-Oertel S; Fralich T
    AIDS; 2014 Jan; 28(3):335-44. PubMed ID: 24670520
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Understanding and controlling chronic immune activation in the HIV-infected patients suppressed on combination antiretroviral therapy.
    Taiwo B; Barcena L; Tressler R
    Curr HIV/AIDS Rep; 2013 Mar; 10(1):21-32. PubMed ID: 23225316
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.